Posts Tagged ‘Kurt Weiss’
Now that many states and localities are starting to lift shelter-in-place restrictions and move into phases of reopening, what do sarcoma patients need to know? As a follow-up to our April session, the Sarcoma Foundation of America is reuniting the panel of sarcoma experts to share their thoughts on how COVID-19 may continue to impact care and what sarcoma patients need to know as we begin the phases of reopening. Our multidisciplinary panel will answer your questions and address concerns on issues of care, the impact on research and clinical trials, and next steps as we move forward. Saturday,… Read More »
In response to the COVID-19 outbreak, the Sarcoma Foundation of America (SFA) held a live, online session with a panel of sarcoma experts to discuss the impact the coronavirus pandemic is having on sarcoma patients and survivors. Panelists Brian Van Tine, MD, PhD, Washington University in St. Louis, Kurt Weiss, MD, University of Pittsburgh School of Medicine, and Breelyn Wilky, MD, University of Colorado Cancer Center, answered questions submitted by the sarcoma community. The panelists shared input on issues related to how on patients can communicate with their physicians on the risks and benefits of current care and treatment… Read More »
Kurt Richard Weiss, MD Assistant Professor, Department of Orthopaedic Surgery, Division of Musculoskeletal Oncology, Director of the Cancer Stem Cell Laboratory, University of Pittsburgh Medical Center 2013 Sarcoma Foundation of America Research Grant Recipient: “Investigation Of Novel Anti-Metastatic Therapy For Osteosarcoma” PLEASE DESCRIBE THE FOCUS OF THE RESEARCH PERFORMED IN YOUR LAB. Although there are dozens of distinct histologic subtypes of sarcoma, they all share one deadly characteristic: the propensity to metastasize (spread) to the lungs. Indeed, pulmonary metastases are the main cause of mortality in sarcoma patients of all ages. Although the… Read More »